524632
SHUKRAPHAR
Start SIP
Invest Now
Start SIP in SHUKRAPHAR
Performance
- Low
- ₹59
- High
- ₹59
- 52 Week Low
- ₹11
- 52 Week High
- ₹65
- Open Price₹59
- Previous Close₹56
- Volume271,888
Investment Returns
- Over 1 Month + 47.12%
- Over 3 Month + 73.79%
- Over 6 Month + 335.91%
- Over 1 Year + 423.71%
Smart Investing Starts Here Start SIP with Shukra Pharmaceuticals for Steady Growth!
Shukra Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 215.2
- PEG Ratio
- -12.6
- Market Cap Cr
- 2,573
- P/B Ratio
- 39.1
- Average True Range
- 2.94
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- 3.97
- RSI
- 64.48
- MFI
- 81.95
Shukra Pharmaceuticals Financials
Shukra Pharmaceuticals Technicals
EMA & SMA
Current Price
₹58.76
+
2.79
(4.98%)
- Bearish Moving Average 0
- Bullish Moving Average 16
- 20 Day
- ₹50.44
- 50 Day
- ₹43.98
- 100 Day
- ₹37.33
- 200 Day
- ₹29.70
Resistance and Support
54.2
- R3 63.06
- R2 59.52
- R1 57.74
- S1 52.42
- S2 48.88
- S3 47.10
Shukra Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-13 | Quarterly Results | |
| 2025-10-03 | Others | Inter-alia, to consider 1. To declare and fix relevant date for the Pproposed preferential issue. 2. fix day, date, time and venue for Extra-ordinary General meeting (EGM). 3. Other business matters. alia, 1. To consider in principle, the issue of equity shares of face value of Rs. 10/- each on a rights basis ("Rights Issue") to the shareholders of the Company. |
| 2025-08-13 | Quarterly Results | |
| 2025-06-04 | Final Dividend | |
| 2025-05-29 | Audited Results |
Shukra Pharmaceuticals F&O
About Shukra Pharmaceuticals
- NSE Symbol
- SHUKRAPHAR
- BSE Symbol
- 524632
- Managing Director
- Mr. Dakshesh Rameshchandra Shah
- ISIN
- INE551C01044
Similar Stocks to Shukra Pharmaceuticals
Shukra Pharmaceuticals FAQs
Shukra Pharmaceuticals share price is ₹58 As on 26 December, 2025 | 15:58
The Market Cap of Shukra Pharmaceuticals is ₹2573 Cr As on 26 December, 2025 | 15:58
The P/E ratio of Shukra Pharmaceuticals is 215.2 As on 26 December, 2025 | 15:58
The PB ratio of Shukra Pharmaceuticals is 39.1 As on 26 December, 2025 | 15:58
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.